Atlas Trials

Human Papillomavirus (HPV)

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Papillomavirus (HPV)

RecordFirmDate
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC (NCT04849377)Icahn School of Medicine at Mount Sinai2022-06-14
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) (NCT03180684)Inovio Pharmaceuticals2017-08-31
New Strategies to Assess Anal Cancer Risk In Women (NCT02873741)Emory University2016-07-01
AMG 319 in HPV Positive and Negative HNSCC (NCT02540928)Cancer Research UK2015-10-01
Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics (NCT03111251)The University of Texas Health Science Center, Houston2015-03-01
Prevalence of HPV Transmission During Medically Assisted Procreation Procedures (NCT02524223)Centre Hospitalier Universitaire de Saint Etienne2012-07-12
Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years (NCT01197079)Ann & Robert H Lurie Children's Hospital of Chicago2010-08-01
Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100 (NCT01188850)Inovio Pharmaceuticals2010-07-01

Track Human Papillomavirus (HPV) automatically

Every clearance here is in the API, with alerts when new ones post.